Mc Glone Suttner Wealth Management, Inc. Bristol Myers Squibb CO Transaction History

Mc Glone Suttner Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $6,108 - $7,289	126 New	126 $6.47 Million
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $184,440 - $204,792	-2,895 Reduced 35.16%	5,338 $341 Million
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $18,595 - $21,091	283 Added 3.56%	8,233 $571 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $544,416 - $644,665	7,950 New	7,950 $572 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mc Glone Suttner Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Glone Suttner Wealth Management, Inc. with notifications on news.